You are using a version of the website built for webcrawlers and people whose devices cannot use javascript.
Some functionality will not be available.
Warning: This page is an archive.
General administrative information and links are not current and should not be used.
Contents (2008 - 392)
Poisons and Therapeutic Goods Regulation 2008
Current version for 1 July 2017 to date (accessed 19 November 2017 at 10:18)
Part 4A Clause 128C
128C   Meaning of medicinal cannabis products
(1)  Subject to subclause (2), in this Part, medicinal cannabis products are therapeutic goods that:
(a)  comprise or contain:
(i)  cannabis, or
(ii)  tetrahydrocannabinols extracted from cannabis or derived from an extract of cannabis, or
(iii)  any other extract, or derivative of an extract, of cannabis, and
(b)  are not registered goods.
Note.
 Medicinal cannabis products are prohibited goods under the Customs Act 1901 of the Commonwealth and may only be imported in accordance with regulations made under that Act. Cannabis plants may only be cultivated, and medicinal cannabis products may only be manufactured, under a licence under the Narcotic Drugs Act 1967 of the Commonwealth.
(2)  The following are not medicinal cannabis products:
(a)  a Schedule 4 substance,
(b)  a Schedule 8 substance comprising Nabiximols (as defined in the Poisons List),
(c)  hemp seed oil containing 50 mg/kg or less of tetrahydrocannabinols extracted from cannabis or derived from an extract of cannabis, when labelled with a warning statement “Not for internal use” or “Not to be taken”,
(d)  other products for purposes other than internal human use containing 50 mg/kg or less of tetrahydrocannabinols extracted from cannabis or derived from an extract of cannabis.
(3)  In this clause:
cannabis means any part of a plant of the genus Cannabis, including its seeds.